← Back to Search

Specialized Early Engagement Support Service for First Episode Psychosis (Interview Trial)

N/A

Waitlist Available

Led By Michael T Compton, M.D., P.H.D.

Research Sponsored by Columbia University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

Interview Trial Summary

This trial is studying a jail-based intervention to reduce the duration of untreated psychosis (DUP) among young adults with previously undetected first-episode psychosis who are detained in jail.

Eligible Conditions

First Episode Psychosis

Interview Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of Referrals to Coordinated Specialty Care (CSC)

Number of Referrals to Correctional Health Services (CHS)

Secondary outcome measures

Changes in Correction Officers' behavioral capability, expectations, and selfefficacy across the duration of the TEC

Survey-based engagement and working alliance between SEET and referred individuals

Interview Trial Design

1Treatment groups

Experimental Treatment

Group I: Specialized Early Engagement Support ServiceExperimental Treatment1 Intervention

The investigators will implement a Specialized Early Engagement Support Service (SEESS) in the same three jails. The SEESS will increase the likelihood that referred individuals found to have first-episode psychosis enroll in Coordinated Specialty Care upon release.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Specialized Early Engagement Support Service

2020

N/A

~10

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor

1,428 Previous Clinical Trials

2,460,112 Total Patients Enrolled

Vera Institute of JusticeUNKNOWN

1 Previous Clinical Trials

451 Total Patients Enrolled

University of Illinois at ChicagoOTHER

606 Previous Clinical Trials

1,559,298 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the criteria for enrolment in this experiment exclude persons aged 35 or older?

"To be eligible for this trial, applicants must range from 18 to 30 years old. In contrast, there are 112 trials solely targeting minors and 257 specifically designed for adults over 65."

Answered by AI

Are there any available vacancies for participants in this medical experiment?

"The details found on clinicaltrials.gov demonstrate that, despite being initially posted in January 2020 and updated last August 2022, this trial is not currently looking for patients. However, 422 other trials are actively recruiting individuals as of now."

Answered by AI

What criteria must a patient meet to be eligible for this research project?

"To be eligible for this clinical trial, potential candidates must have a documented psychotic disorder and fall between the ages of 18 to 30. A total of 8 participants are required for recruitment across multiple sites."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Clinical Interviews With Detainees With Early Psychosis

Michael Compton 2020. "Clinical Interviews With Detainees With Early Psychosis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03962348.